Literature DB >> 3348310

Infertility among daughters either exposed or not exposed to diethylstilbestrol.

E K Senekjian1, R K Potkul, K Frey, A L Herbst.   

Abstract

Infertility was examined among 343 diethylstilbestrol-exposed and 303 unexposed daughters whose mothers participated in an evaluation of diethylstilbestrol use during pregnancy 35 years ago. Of the married individuals who were not using contraception and who were actively trying to conceive, a greater proportion of diethylstilbestrol-exposed women than unexposed subjects experienced primary infertility (33% versus 14%, p less than 0.001). Among those with primary infertility, abnormal hysterosalpingograms were observed in 46% of the diethylstilbestrol-exposed group and in none of the unexposed group (p less than 0.02), while tubal abnormalities were found in 42% of the exposed and in none of the unexposed (p = 0.02). First pregnancies were achieved by 40 (58%) women exposed to diethylstilbestrol and 18 (64%) unexposed subjects. Twenty-four (60%) of the exposed women and 15 (83%) of the unexposed individuals who conceived had a live-born infant who survived. The estimated cumulative rate of first pregnancy was 16% for the exposed group and 36% for the unexposed group at 12 months after the diagnosis of primary infertility (p less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3348310     DOI: 10.1016/0002-9378(88)90012-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  The daughters of stilboestrol.

Authors:  M Wingfield
Journal:  BMJ       Date:  1991-06-15

2.  Birth defects in the sons and daughters of women who were exposed in utero to diethylstilbestrol (DES).

Authors:  L Titus-Ernstoff; R Troisi; E E Hatch; J R Palmer; M Hyer; R Kaufman; E Adam; K Noller; R N Hoover
Journal:  Int J Androl       Date:  2009-11-30

Review 3.  Exposure to diethylstilbestrol during sensitive life stages: a legacy of heritable health effects.

Authors:  Casey E Reed; Suzanne E Fenton
Journal:  Birth Defects Res C Embryo Today       Date:  2013-06

Review 4.  Polycystic ovary syndrome and its developmental origins.

Authors:  Daniel A Dumesic; David H Abbott; Vasantha Padmanabhan
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

5.  Exposure to female hormone drugs during pregnancy: effect on malformations and cancer.

Authors:  E Hemminki; M Gissler; H Toukomaa
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

6.  Child outcomes after placement of a cervical pessary in women with a multiple pregnancy: A 4-year follow-up of the ProTWIN trial.

Authors:  Noor E Simons; Cornelieke van de Beek; Johanna H van der Lee; Brent C Opmeer; Aleid G van Wassenaer-Leemhuis; Anneloes L van Baar; Leonie Steenis; Sophie Liem; Ewoud Schuit; Dick Bekedam; Ben W J Mol; Janneke Van't Hooft
Journal:  Acta Obstet Gynecol Scand       Date:  2019-06-18       Impact factor: 3.636

Review 7.  Oestrogen supplementation, mainly diethylstilbestrol, for preventing miscarriages and other adverse pregnancy outcomes.

Authors:  A A Bamigboye; J Morris
Journal:  Cochrane Database Syst Rev       Date:  2003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.